Mission Bio is a life sciences company that accelerates discoveries and cures by equipping researchers with the tools they need to improve how we measure and predict our resistance and response to precision therapies. With the Tapestri Platform, the only commercialized platform capable of analyzing DNA and protein simultaneously with single-cell resolution, Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health.
MgenOway is a biotechnology company with over 20 years of expertise in the development of physiologically relevant preclinical models. The company has developed a catalog of humanized, "off the-shelf" immuno-oncology mouse and cell models to accelerate research into cancer pathophysiology and enable the evaluation of new therapeutic agents. Founded in 1999, genOway currently operates in more than 28 countries with 380 academic institutions and 170 life science companies, including 17 of the top 20 pharmaceutical companies.